These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6979804)

  • 1. The history and background of Augmentin.
    Rolinson GN
    S Afr Med J; 1982 Jul; 62(5 Spec No):3A-4A. PubMed ID: 6979804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentin: laboratory studies.
    Farrell ID; Turner PJ
    Scott Med J; 1982; 27 Spec No.():S21-3. PubMed ID: 6762661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC; Barry AL
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Mar; 13(3):389-93. PubMed ID: 122520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentin: an in vitro study of bacterial sensitivities to a synergistic combination.
    Neville MA
    N Z Med J; 1982 Aug; 95(714):579-81. PubMed ID: 6982440
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
    Matsuura M; Nakazawa H; Hashimoto T; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jun; 17(6):908-11. PubMed ID: 6967713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
    Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
    Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE; Slocombe B; White AR
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of β-lactamase-producing bacteria in human periodontitis.
    Rams TE; Degener JE; van Winkelhoff AJ
    J Periodontal Res; 2013 Aug; 48(4):493-9. PubMed ID: 23173872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of beta-lactamase inhibitors.
    Rolinson GN
    Surg Gynecol Obstet; 1991; 172 Suppl():11-6. PubMed ID: 2024221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with amoxicillin and clavulanic acid of urinary tract infections in patients with spinal injuries].
    Du Plessis DJ; Celliers D; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):8A-11A. PubMed ID: 6979806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentin treatment of bacterial infections in hospitalised patients.
    Ellis-Pegler RB; Lang SD; Downey DJ; Anderson MP
    N Z Med J; 1982 Aug; 95(713):542-5. PubMed ID: 6752781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
    Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
    Billal DS; Hotomi M; Yamanaka N
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.